Evogene : Q1 2024 Consolidated Financial Statements
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF...
Stay updated with breaking news from Verb Biotics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF...
Conference call and webcast: today, May 23, 2024, 9:00 am ET Financial and Business Highlights: Q1 2024 revenue: $4.2M vs. $0.6M in Q1 2023; anticipating...
Conference call and webcast: today, May 23, 2024, 9:00 am ET Financial and Business Highlights: Q1 2024 revenue: $4.2M vs. $0.6M in Q1 2023; anticipating continued growth in 2024. Q1 2024 net loss:...
A new study has found that a multi-strain probiotics formula cuts the level of a bone loss marker for a group of post-menopausal women, whom are most at risk for osteoporosis.
Discover how Verb Biotics and Evogene’s partnership accelerates probiotic development using AI-driven technology. Learn about MicroBoost AI and the genetic pathways unlocking microbial secrets, revolutionizing the industry’s product innovation.